Skip to main content
Top
Published in: Esophagus 1/2016

01-01-2016 | Original Article

Characteristics and diagnosis of esophageal basaloid squamous cell carcinoma

Authors: Rieko Nakamura, Tai Omori, Hiroya Takeuchi, Hirofumi Kawakubo, Tsunehiro Takahashi, Norihito Wada, Yoshiro Saikawa, Kaori Kameyama, Yuko Kitagawa

Published in: Esophagus | Issue 1/2016

Login to get access

Abstract

Background

Basaloid squamous cell carcinoma (BSCC) is a relatively rare, malignant disease of the esophagus. The prognosis of patients with BSCC is thought to be poorer than that of typical squamous cell carcinoma (SCC), but the treatment strategy for BSCC is generally the same as that for typical SCC. This study examined the diagnosis, the clinical and pathological characteristics, and the results of therapy in patients with BSCC.

Methods

The medical records for 13 patients with pathologically confirmed esophageal BSCC were extracted. The pretreatment endoscopic diagnosis and the pathological diagnosis after resection were reviewed for each patient, and the histological features and patient outcome were examined. We especially focus on histological difference and endoscopic findings of the 13 patients with BSCC.

Results

Macroscopically, BSCC was mainly visualized as an elevated lesion with normal epithelium on the surface layer which indicated the tumor growth into submucosa. Further pathological examination allowed the 13 BSCC patients to be grouped into 2 groups according to differences in the microscopic appearances of the BSCC cancer cells: a typical BSCC pattern and a pattern similar to that of poorly differentiated SCC. Six of the patients who received an esophagectomy as the primary treatment died, and only 1 patient survived. Two patients who received chemoradiotherapy before an esophagectomy did not develop recurrences. Almost all the patients who died as a result of the recurrence of esophageal cancer had a lymph node recurrence. Prognoses of BSCCs with a pattern similar to that of poorly differentiated SCC without preoperative chemotherapy were poorer than BSCCs with a typical BSCC pattern, while BSCC with a pattern similar to poorly differentiated SCC with preoperative chemotherapy showed good prognoses than BSCC without preoperative chemotherapy.

Conclusions

BSCC esophageal cancer mainly appears as an elevated lesion with submucosal growth, which can be diagnosed preoperatively by understanding of macroscopic characteristics of esophageal BSCC. The outcome of the BSCC patients in the present study was relatively poor, while pretreatment diagnosis of BSCC influences the strategy of treatment and pathological diagnosis including histological difference of BSCC may lead to appropriate treatment and better prognosis of esophageal BSCC.
Literature
1.
go back to reference Takubo K, Mafune K, Tanaka Y, Miyama T, Fujita K. Basaloid-squamous carcinoma of the esophagus with marked deposition of basement membrane substance. Acta Pathol Jpn. 1991;41:59–64.PubMed Takubo K, Mafune K, Tanaka Y, Miyama T, Fujita K. Basaloid-squamous carcinoma of the esophagus with marked deposition of basement membrane substance. Acta Pathol Jpn. 1991;41:59–64.PubMed
2.
go back to reference Rubio CA, Liu FS. The histogenesis of microinvasive basal cell carcinoma of the esophagus. Pathol Res Pract. 1990;186:223–7.PubMedCrossRef Rubio CA, Liu FS. The histogenesis of microinvasive basal cell carcinoma of the esophagus. Pathol Res Pract. 1990;186:223–7.PubMedCrossRef
3.
go back to reference Abe K, Sasano H, Itakura Y, Nishihira T, Mori S, Nagura H. Basaloid-squamous carcinoma of the esophagus. A clinicopathologic, DNA ploidy, and immunohistochemical study of seven cases. Am J Surg Pathol. 1996;20:453–61.PubMedCrossRef Abe K, Sasano H, Itakura Y, Nishihira T, Mori S, Nagura H. Basaloid-squamous carcinoma of the esophagus. A clinicopathologic, DNA ploidy, and immunohistochemical study of seven cases. Am J Surg Pathol. 1996;20:453–61.PubMedCrossRef
4.
go back to reference Vaaudev P, Boutross-Tadross O, Radhi J. Basaloid squamous cell carcinoma: two case reports. Cases J. 2009;2:9351.CrossRef Vaaudev P, Boutross-Tadross O, Radhi J. Basaloid squamous cell carcinoma: two case reports. Cases J. 2009;2:9351.CrossRef
5.
go back to reference Cho KJ, Jang JJ, Lee SS, Zo JI. Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation. Histopathology. 2000;36(4):331–40.PubMedCrossRef Cho KJ, Jang JJ, Lee SS, Zo JI. Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation. Histopathology. 2000;36(4):331–40.PubMedCrossRef
6.
go back to reference Schaefer IM, Enders C, Polten A, Haller F, Frölich AM, Cameron S, et al. Common genomic aberrations in basaloid squamous cell carcinoma and carcinosarcoma of the esophagus detected by CGH and array CGH. Am J Clin Pathol. 2011;135(4):579–86.PubMedCrossRef Schaefer IM, Enders C, Polten A, Haller F, Frölich AM, Cameron S, et al. Common genomic aberrations in basaloid squamous cell carcinoma and carcinosarcoma of the esophagus detected by CGH and array CGH. Am J Clin Pathol. 2011;135(4):579–86.PubMedCrossRef
7.
go back to reference Chen SB, Weng HR, Wang G, Yang JS, Yang WP, et al. Basaloid squamous cell carcinoma of the oesophagus. J Cancer Res Clin Oncol. 2012;138:1165–71.PubMedCrossRef Chen SB, Weng HR, Wang G, Yang JS, Yang WP, et al. Basaloid squamous cell carcinoma of the oesophagus. J Cancer Res Clin Oncol. 2012;138:1165–71.PubMedCrossRef
8.
go back to reference Imamhasan A, Mitomi H, Saito T, Hayashi T, Takahashi M, Kajiyama Y, et al. Immunohistochemical and oncogenetic analyses of esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Hum Pathol. 2012;43:2012–23.PubMedCrossRef Imamhasan A, Mitomi H, Saito T, Hayashi T, Takahashi M, Kajiyama Y, et al. Immunohistochemical and oncogenetic analyses of esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Hum Pathol. 2012;43:2012–23.PubMedCrossRef
9.
go back to reference Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17:1158–66.PubMedCrossRef Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17:1158–66.PubMedCrossRef
10.
go back to reference The Japan Esophageal Society. Japanese Classification of Esophageal Cancer. 10th ed 2008 (Revised version). The Japan Esophageal Society. Japanese Classification of Esophageal Cancer. 10th ed 2008 (Revised version).
11.
go back to reference Ohashi K, Horiguchi S, Moriyama S, Hishima T, Hayashi Y, Momma K, et al. Superficial basaloid squamous carcinoma of the esophagus. A clinicopathological and immunohistochemical study of 12 cases. Pathol Res Pract. 2003;199(11):713–21.PubMed Ohashi K, Horiguchi S, Moriyama S, Hishima T, Hayashi Y, Momma K, et al. Superficial basaloid squamous carcinoma of the esophagus. A clinicopathological and immunohistochemical study of 12 cases. Pathol Res Pract. 2003;199(11):713–21.PubMed
12.
go back to reference Zhang XH, Sun GQ, Ahou XJ, Guo HF, Zhang TH. Basaloid squamous carcinoma of the esophagus: a clinicopathological, immunohistological and electron microscopic study of sixteen cases. World J Gastroenterol. 1998;4:297–403. Zhang XH, Sun GQ, Ahou XJ, Guo HF, Zhang TH. Basaloid squamous carcinoma of the esophagus: a clinicopathological, immunohistological and electron microscopic study of sixteen cases. World J Gastroenterol. 1998;4:297–403.
13.
go back to reference Sarbia M, Verreet P, Bittinger F, Dutkowski P, Heep H, Willers R, et al. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer. 1997;79:1871–8.PubMedCrossRef Sarbia M, Verreet P, Bittinger F, Dutkowski P, Heep H, Willers R, et al. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer. 1997;79:1871–8.PubMedCrossRef
14.
go back to reference Li TJ, Zhang YX, Wen J, Cowan DF, Hart J, Xiao SY. Basaloid squamous cell carcinoma of the esophagus with and without adenoid cystic features. Arch Pathol Lab Med. 2004;128:1124–30.PubMed Li TJ, Zhang YX, Wen J, Cowan DF, Hart J, Xiao SY. Basaloid squamous cell carcinoma of the esophagus with and without adenoid cystic features. Arch Pathol Lab Med. 2004;128:1124–30.PubMed
15.
go back to reference Zhang BH, Cheng GY, Xue Q, Gao SG, Sun KL, Wang YG, et al. Clinical outcomes of Basaloid squamous cell carcinoma of the esophagus: a retrospective analysis of 142 cases. Asian Pacific J Cancer Prev. 2013;14(3):1889–94.CrossRef Zhang BH, Cheng GY, Xue Q, Gao SG, Sun KL, Wang YG, et al. Clinical outcomes of Basaloid squamous cell carcinoma of the esophagus: a retrospective analysis of 142 cases. Asian Pacific J Cancer Prev. 2013;14(3):1889–94.CrossRef
16.
go back to reference Lam KY, Law S, Luk JM, Wong J. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as prognostic indicator. J Pathol. 2001;195:435–42.PubMedCrossRef Lam KY, Law S, Luk JM, Wong J. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as prognostic indicator. J Pathol. 2001;195:435–42.PubMedCrossRef
17.
go back to reference Ohashi K, Horiguchi S, Moriyama S, Hishima T, Hayashi Y, Momma K, et al. Superficial basaloid squamous cell carcinoma of the esophagus. A clinicopathological and immunohistological study of the 12 cases. Pathol Res Pract. 2003;199(11):713–21.PubMed Ohashi K, Horiguchi S, Moriyama S, Hishima T, Hayashi Y, Momma K, et al. Superficial basaloid squamous cell carcinoma of the esophagus. A clinicopathological and immunohistological study of the 12 cases. Pathol Res Pract. 2003;199(11):713–21.PubMed
18.
go back to reference The Japanese society for esophageal diseases:comprehensive registry of Esophageal cancer in Japan(1998,1999). 3rd ed, 2002. The Japanese society for esophageal diseases:comprehensive registry of Esophageal cancer in Japan(1998,1999). 3rd ed, 2002.
19.
go back to reference Luna MA, Parichatikanond P, Weber RS. BatsakisJG: Basaloid squamous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer. 1990;66:537–42.PubMedCrossRef Luna MA, Parichatikanond P, Weber RS. BatsakisJG: Basaloid squamous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer. 1990;66:537–42.PubMedCrossRef
20.
go back to reference Kobayashi Y, Nakanishi Y, Taniguchi H, Sekine S, Igaki H, Tachimori Y, et al. Histological diversity in basaloid squamous cell carcinoma of the esophagus. Disease of the esophagus. 2009;22:231–8.CrossRef Kobayashi Y, Nakanishi Y, Taniguchi H, Sekine S, Igaki H, Tachimori Y, et al. Histological diversity in basaloid squamous cell carcinoma of the esophagus. Disease of the esophagus. 2009;22:231–8.CrossRef
Metadata
Title
Characteristics and diagnosis of esophageal basaloid squamous cell carcinoma
Authors
Rieko Nakamura
Tai Omori
Hiroya Takeuchi
Hirofumi Kawakubo
Tsunehiro Takahashi
Norihito Wada
Yoshiro Saikawa
Kaori Kameyama
Yuko Kitagawa
Publication date
01-01-2016
Publisher
Springer Japan
Published in
Esophagus / Issue 1/2016
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-015-0490-8

Other articles of this Issue 1/2016

Esophagus 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.